Swedish biotech SymCel has signed on a new beta-tester at an undisclosed company for its calorimetry-based live-cell screening device, its third overall beta placement and first at a commercial entity, the company's CEO told CBA News last week.

A parallel development to the increasing interest in high-content cellular-imaging has been a decidedly simpler approach to live-cell screening using label-free technology, most of which measures physical cellular characteristics to determine general cell health, and in some cases, specific compound effects.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers have sequenced the northern white rhinoceros to gauge whether it could be brought back from the edge of extinction, the New York Times reports.

Bavaria expands its forensic genetic analyses to include DNA phenotyping, raising discrimination concerns.

Tufts University researchers found a role for miRNA in transmitting stress between generations, the Economist reports.

In Science this week: gut microbiome influences liver cancer growth, spread; and more.